1[1]Wong B, Murphy J, Chang CJ, et al. The risk of pericardiocemesis. Am J Cardiol, 1979,44(6): 1110.
2[2]Moriya T, Takiguchi Y, Tabeta H, et al. Controlling malignant pericardial effusion by intrapericardial carboplatin administration in patients with primary non-mll-cell lung cancer. Br J Cancer,2000,83(7) :858.
3[3]Dempke W, Firusian N. Treatment of malignant pericardial effusion with 32P-colloid. Br J Cancer, 1999,80(12): 1955.
4[4]Celleoni M, Martinelli G, Beretta F, et al. Intracavitary chemotherapy with thiotepa in malignant pericardial effusions: an active and well tolerated regimen. J Clin Oncol, 1998, 16(7):2371.
5[5]Sobol SM, Thomas HM Jr, Evans RW. Myocardial laceration not demonstrated by continuous electrocardiographic monitoring occurring during pericardiocentesis. N Engl J Med, 1975, 292 (23):1222.
6[7]Kopecky SL, Callahan JA, Tajik AJ, et al. Percutaneous pericardial catheter drainage: report of 42 consecutive cases. Am J Cardiol,1986,58(7) :633.
7[8]Zahn EM, Houde C. Benton L, et al. Percutaneous pericardial catheter drainage in childhood. Am J Cardiol, 1992,70(6) :678.
8[9]Braunwald E. Heart Disease. ed 5. Philadephia Saunders Company,1997,1494
9[10]Glancy DL, Richter MA. Catheter drainage of the pericardial space. Cathet Cardiovasc Diagn, 1975,1 (3) :311.
10[1]E Broudwald. Heart disease: a textbook of cardiovascular medicine[ M ].5Ed. W. B. Saunders Company, Philadelphia, 1997.1492 - 1495.
